Major gaps in our picture of host resistance to M. tuberculosis (Mtb) include a lack of understanding of the biochemical basis of the restriction of Mtb replication by activated macrophages, lack of experimental approaches to the evaluation of an antituberculous contribution by the respiratory epithelium, and ignorance of the genetic and biochemical bases of mycobacterial resistance to host anti-tuberculous defenses. Improved antituberculous therapy might result from better understanding of each of these points, as well as from the development of an otherwise healthy, inexpensive laboratory animal in which Mtb can replicate as quickly as it is intrinsically able. The present experiments are designed to address each Of these points from the perspective of the hypothesis that the inducible form of nitric oxide synthase (iNOS) may play a major anti-tuberculous role. Genetic approaches that knock out iNOS selectively in the whole mouse or mainly in macrophages, or express iNOS mainly in macrophages or respiratory epithelium, will include homologous recombination, adenovirus- assisted transfection, and transgenic expression controlled by a cell type-restricted promoter. Second, we will use iNOS-deficient and wild type mice to screen differentially for Mtb genes, expressed in recombinant E. coli, that confer resistance or sensitivity to host nitroxergic defenses. The level of resistance or sensitivity will be analyzed by comparing the survival of these organisms in mice, in cultures of mammalian cells transfected with iNOS cDNA, and in culture medium containing NO-generating compounds. Third, we will explore the relevance of the murine findings to man by probing pathologic specimens from tubercular and control subjects with a new antibody to human iNOS and with restricted cDNA from human iNOS. These experiments should provide an unambiguous answer to the importance of iNOS in defense of the murine lung against Mtb, and should help differentiate between the contribution of NO arising from macrophages and from respiratory epithelium. We may generate mice whose immune system and overall physiology have undergone, the least perturbation consistent with allowing Mtb to replicate rapidly. Moreover, these experiments will shed light on the genetic basis of mycobacterial virulence, insofar as it relates to NO as a host defense mechanism against TB. Finally, these studies should establish whether iNOS is expressed in the tubercular human lung.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL051967-01
Application #
3370527
Study Section
Special Emphasis Panel (ZHL1-CSR-N (S3))
Project Start
1993-09-30
Project End
1998-08-31
Budget Start
1993-09-30
Budget End
1994-08-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Firmani, Marcia A; Riley, Lee W (2002) Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro. Infect Immun 70:3965-8
Firmani, Marcia A; Riley, Lee W (2002) Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro. J Clin Microbiol 40:3162-6
Stewart, G R; Ehrt, S; Riley, L W et al. (2000) Deletion of the putative antioxidant noxR1 does not alter the virulence of Mycobacterium tuberculosis H37Rv. Tuber Lung Dis 80:237-42
Murray, H W; Nathan, C F (1999) Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189:741-6
Ruan, J; St John, G; Ehrt, S et al. (1999) noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. Infect Immun 67:3276-83
Shiloh, M U; MacMicking, J D; Nicholson, S et al. (1999) Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10:29-38
Chen, L; Xie, Q W; Nathan, C (1998) Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol Cell 1:795-805
Karupiah, G; Chen, J H; Mahalingam, S et al. (1998) Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J Exp Med 188:1541-6
Karupiah, G; Chen, J H; Nathan, C F et al. (1998) Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection. J Virol 72:7703-6
Friedman, C R; Quinn, G C; Kreiswirth, B N et al. (1997) Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J Infect Dis 176:478-84

Showing the most recent 10 out of 17 publications